Bristol-Myers Squibb buy UBS Group AG
Start price
07.01.26
/
50%
€47.50
Target price
07.01.27
€55.55
Performance (%)
-0.22%
Price
02.02.26
€47.40
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Bristol-Myers Squibb is nearly unchanged. This prediction currently runs until 07.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Bristol-Myers Squibb | 3.156% |
| iShares Core DAX® | -0.436% |
| iShares Nasdaq 100 | 0.854% |
| iShares Nikkei 225® | 2.652% |
| iShares S&P 500 | 1.190% |
Comments by UBS_Group_AG for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $65.00 price target on the stock.
Ratings data for BMY provided by MarketBeat